Avenue Therapeutics
Oct 13, 2020
US/AZ deal; Alkermes’ Schizophrenia drug; Innovent/Lilly’s China market expansion; Rejection for Avenue
U.S., AstraZeneca strikes an antibody treatment USD 486 million deal The U.S. government awarded the pharma giant AstraZeneca a sum of USD 486 million for the development of up to 100,000 corona vaccine doses. The deal, under Operation Warp Speed, will people the manufacturing of antibody doses and facilitate th...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
